Showing 2131-2140 of 9404 results for "".
Verisante
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/verisante-/19449/News Reel on Vancouver, BC based Verisante discussing the company's partnership with BCCA (British Columbia Cancer Agency) to develop a new product for early skin cancer detection.Sciton SkinTyte - Patient Testimonials
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/sciton-skintyte-patient-testimonials-/19465/Sciton SkinTyte patients describe the before, during, and after effects of the procedure.DermWireTV Extra: Dr. Bhatia and Dr. Schlesinger Discuss Collaboration With Oncologists
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dr-bhatia-and-dr-schlesinger-discuss-collaboration-oncologists/26304/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, and Editorial Board member Todd Schlesinger, MD, discuss the importance of collaborating with oncologists on advanced skin cancer cases as immunotherapy technology continues to progress.Science of Skincare Summit 2024:The Latest in Exosomes
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-the-latest-in-exosomes/29450/Practical Dermatology talks with Todd Schlesinger, MD, a dermatologist and Mohs surgeon, and a member of the Editorial Board, about the latest updates in exosomes and what to expect next. This video was recorded at the Science of Skincare Summit in Austin.ISDPA: Dr. Bhatia and Dr. Zirwas Discuss the Itchy Patient
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-bhatia-and-dr-zirwas-discuss-itchy-patient/27065/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks with Matthew Zirwas, MD, about Dr. Zirwas’s lecture on the itchy patient and the latest solutions for itch at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.Dysregulation of Type 2 Immune Pathway
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/dysregulation-of-type-2-immune-pathway/48788/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the role of type 2 inflammatory response in immune dysregulation in atopic dermatitis.Improving Care Options for CTCL
https://practicaldermatology.com/series/c-suite-chats/improving-care-options-for-ctcl/48714/Greg Palko, Vice President, North America, and Oncology Franchise Head for Kyowa Kirin, discusses the challenges posed by cutaneous T-cell lymphoma and efforts to address those issues.Are You Sure?
https://practicaldermatology.com/issues/april-2025/are-you-sure/35604/We are to treat patients in 3D, reminding them of the value of touch, of conversation, and of relationships. In the end, that’s what it’s all about.The Latest in Blistering Diseases
https://practicaldermatology.com/programs/practical-dermatology/the-latest-in-blistering-diseases/33007/Kim B. Yancey, MD, a professor of dermatology at UT Southwestern Medical Center in Dallas, talks about current treatments and techniques for blistering diseases, focusing specifically autoimmune blistering diseases.Masterclasses in Dermatology: The Importance of Interdisciplinary Teaching
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/masterclasses-in-dermatology-the-importance-of-interdisciplinary-teaching/33021/Masterclasses in Dermatology 2025 course directors Alice Gottlieb, MD, a dermatologist and rheumatologist at Mount Sinai, and Joseph Merola, MD, MMSc, chair and professor of dermatology at UT Southwestern Medical Center in Dallas, talk about the value of interdisciplinary education and collaboration